Iron gets in the way.
atherosclerosis
cell biology
estrogen receptor α
hormone replacement therapy
iron metabolism
mouse
postmenopause
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
10 08 2023
10 08 2023
Historique:
medline:
11
8
2023
pubmed:
10
8
2023
entrez:
10
8
2023
Statut:
epublish
Résumé
Accumulation of iron with age may inhibit the benefits of hormone replacement therapy on cardiovascular disease in late postmenopause.
Identifiants
pubmed: 37561017
doi: 10.7554/eLife.90743
pii: 90743
pmc: PMC10414964
doi:
pii:
Substances chimiques
Iron
E1UOL152H7
Types de publication
Editorial
Comment
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentOn
Informations de copyright
© 2023, Singh and Malhotra.
Déclaration de conflit d'intérêts
KS, RM No competing interests declared
Références
Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):178-187
pubmed: 30587002
JAMA. 2002 Jul 17;288(3):321-33
pubmed: 12117397
JAMA. 1998 Aug 19;280(7):605-13
pubmed: 9718051
Cochrane Database Syst Rev. 2015 Mar 10;(3):CD002229
pubmed: 25754617
Cell Biosci. 2020 Nov 26;10(1):137
pubmed: 33292517
J Am Coll Cardiol. 1999 Jun;33(7):2030-7
pubmed: 10362210
Pharmacol Ther. 2019 Nov;203:107387
pubmed: 31271793
Prev Med. 1991 Jan;20(1):47-63
pubmed: 1826173
N Engl J Med. 2016 Mar 31;374(13):1221-31
pubmed: 27028912
Mol Cell Endocrinol. 2014 May 25;389(1-2):7-12
pubmed: 24508665
JAMA. 2002 Feb 6;287(5):591-7
pubmed: 11829697
Elife. 2023 Aug 10;12:
pubmed: 37561022